For the second year in a row, UC Davis Cancer Center ranked first among the 283 research institutions
in the Southwest Oncology Group for the number of patients enrolled in cancer clinical trials. The cancer
center and its affiliates enrolled 262 patients in SWOG trials between January and December 2002.
The cancer center also ranked seventh among the 250 research institutions in the Radiation Therapy Oncology
Group for the number of patients enrolled in cancer clinical trials during the first quarter of this year.
"Advances in cancer treatment depend on clinical trials," said Kelly Avery, clinical research administrator
at UC Davis Cancer Center. "We're very pleased with the number and variety of trials we have open, and
with our ability to provide investigational treatments to cancer patients in our region."
Sponsored by the National Cancer Institute, the Southwest Oncology Group is one of the largest adult
cancer clinical trials organizations in the world. Its membership consists of nearly 4,000 of the nation's
leading physicians at 283 institutions throughout the United States and Canada.